Chemotherapy in Advanced Non-Small Cell Lung Cancer: Present and Future
Chemotherapy in the status of treating advanced Non-Small Cell Lung Cancer (NSCLC) was established in 1995. Many researches proved that chemotherapy could significantly improve overall survival (OS) and reduce the risk of death in patients with advanced NSCLC when compared with supportive care. Trea...
Main Author: | Yu ZHANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Third Party Medicine International Publishing Group Co. Limited
2017-03-01
|
Series: | Journal of International Translational Medicine |
Subjects: | |
Online Access: | http://www.jitm.hk/EN/abstract/abstract239.shtml |
Similar Items
-
Chemotherapy for Lung Cancer in the Era of Personalized Medicine
by: Seung Hyeun Lee, M.D., Ph.D.
Published: (2019-04-01) -
Recent Advances and Future Strategies for Small Cell Lung Cancer
by: Weipeng SHAO, et al.
Published: (2017-06-01) -
Emerging therapies for small cell lung cancer
by: Sen Yang, et al.
Published: (2019-05-01) -
Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer
by: Yuxin Mu, et al.
Published: (2020-04-01) -
Immunotherapy Combined with Chemotherapy as a Promising Therapy for a EGFR Exon 19 Deletion with MET Amplification Patient with Non-Small-Cell Lung Cancer: A Case Report
by: Ni Q, et al.
Published: (2020-04-01)